High impact company profile available at BioMarket

Smith & Nephew is a diversified medical technology group specializing in orthopaedic reconstruction, orthopaedic trauma and clinical therapies, endoscopy and advanced wound management products. The group acquired two companies, Plus Orthopedics and

High impact company profile available at BioMarket

Detailed information on the current drug pipeline. This report provides insight into the pipeline status of caries drugs by company and by stage as well as a summary of the latest news and developments in this area.

Hologic Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Detailed information on the current drug pipeline. This report provides insight into the pipeline status of diabetic neuropathy drugs by company and by stage as well as a summary of the latest news and developments in this area.

This report provides research and objective analysis of Brazilian biofuel industry. This report helps clients.

This analysis examines the historical and forecast performance for Gilead in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sale

The Johnson & Johnson Partnering Guide 2008 provides an in-depth insight into the dealmaking interests and activity of one of the worlds leading biopharma companies

The market penetration for insomnia drugs has not reached saturation point. Opportunities remain. But with the introduction of several new products the market is set to see changes, but expansion. This expansion is based on increased general awareness

The purpose of this report is to describe the specific market segments for blood glucose testing and diabetes management.

Provides analysis of recent events in the osteoarthritis disease area and their impact on the market. Includes an event-based, indication-specific ten year forecast of both pipeline and marketed products to 2017 in the seven major markets (7MM).

An estimated 34 million people are diagnosed with asthma in the major markets. The disease can be broken down into various phenotypes, differentiated by severity, trigger, or predominant inflammatory type. These phenotypes may have important consequenc

The Amgen Partnering Guide 2008 provides an in-depth insight into the dealmaking interests and activity of one of the worlds leading biopharma companies

The Mundipharma Pharma Partnering Guide 2008 provides an in-depth insight into the dealmaking interests and activity of one of the worlds leading biopharma companies

This analysis examines the historical and forecast performance for Chugai in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sale

This report is written for you to identify your competition and understand which targeting strategies are at work within anti-angiogenic drug development in oncology. It allows you to pin-point which competitors drugs’ clinical out-come may have

Detailed information on the current drug pipeline. This report provides insight into the pipeline status of pneumonia drugs by company and by stage as well as a summary of the latest news and developments in this area.

Assessment and forecast for marketed and late-stage development antiretrovirals in the 7MM, including a snapshot of ROW snapshot and a case study on the Canadian market, which surpasses Japan’s in size for this indication.

On a global basis, the drug development process is becoming increasingly complex, time consuming and expensive.

The UI market is set to continue to grow over the next 6 years, reaching over $2.5 billion in 2012, a 68% increase from 2006. Lifecycle management strategies, novel formulations and follow-on products will drive the majority of this growth, with key br

High impact company profile available at BioMarket

This updated and detailed research evaluates the past, current and future scenario of the global nanotechnology market coupled with an overview on its emerging trends.

Noven Pharmaceuticals Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

An analysis of the market conditions driving the adoption of electronic health records.

Pharmaceuticals in Germany industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry.

This analysis examines the historical and forecast performance for BMS in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f

This report focuses on the world nutraceuticals and dietary supplements markets. The product categories examined include vitamins, minerals, herbal and non-herbal extracts.

This report provides a detailed epidemiological analysis of major indications within the CNS disorders market, and examines the factors impacting their prevalence.